复发性肛门癌的治疗

IF 2.4 4区医学 Q3 ONCOLOGY

Surgical Oncology Clinics of North America Pub Date : 2024-10-24 DOI:10.1016/j.soc.2024.07.005

James Blake Littlejohn MD, Kelly Ann Brister MD

引用次数: 0

摘要

高达 27% 的肛门鳞状细胞癌患者在完成化疗后会出现局部失败或复发。应通过多模式成像进行全面的重新分期，以评估局部疾病和远处转移的程度。多学科肿瘤委员会和必要专科的广泛讨论对于评估R0切除的可能性至关重要。建议通过腹会阴切除术和可能的外展手术进行R0切除的挽救手术，并使用带蒂皮瓣进行会阴重建。五年总生存率为 50%。复发性肛门鳞状细胞癌的成功治疗有赖于对患者的精心选择、多学科合作和R0切除。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Management of Recurrent Anal Cancer

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Surgical Oncology Clinics of North America 医学-外科

CiteScore

3.90

自引率

0.00%

发文量

审稿时长

12 months

期刊介绍： Published four times each year—January, April, July, and October—Surgical Oncology Clinics of North America updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in surgical oncology, including pancreatic cancer, radiation oncology, breast cancer, colorectal cancer, head and neck cancer, palliative care, gene therapy, sarcomas, cancer screening, treatment of colorectal cancer, biliary tract and primary liver tumors, breast cancer, imaging, and more.